Publikace
- Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies2024 | 1. lékařská fakulta
- Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis2024 | 1. lékařská fakulta
- Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom2024 | 1. lékařská fakulta
- Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries2023 | 1. lékařská fakulta, 3. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Hradci Králové, Lékařská fakulta v Plzni
- Is breastfeeding in MS harmful or not? An answer from real-world Czech data2023 | 1. lékařská fakulta, 3. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Hradci Králové, Lékařská fakulta v Plzni
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | 1. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové, Lékařská fakulta v Plzni
- Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis2023 | 1. lékařská fakulta, 3. lékařská fakulta
- Dietní přístupy specifické pro pacienty s roztroušenou sklerózou2023 | 1. lékařská fakulta
- Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis2023 | 1. lékařská fakulta
- Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants2023 | 1. lékařská fakulta
Loading network view...